{
    "organizations": [],
    "uuid": "9c028021844683aa2cdb2983466b3a610d4885ce",
    "author": "",
    "url": "https://www.reuters.com/article/brief-argenx-announces-orphan-drug-desig/brief-argenx-announces-orphan-drug-designation-for-argx-113-for-treatment-of-myasthenia-gravis-in-europe-idUSFWN1R8015",
    "ord_in_thread": 0,
    "title": "BRIEF-Argenx ‍Announces Orphan Drug Designation For Argx-113 For Treatment Of Myasthenia Gravis In Europe​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - ARGENX NV:\n* ‍ANNOUNCES ORPHAN DRUG DESIGNATION FOR ARGX-113 FOR TREATMENT OF MYASTHENIA GRAVIS IN EUROPE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-26T08:11:00.000+03:00",
    "crawled": "2018-03-26T08:31:48.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "argenx",
        "nv",
        "orphan",
        "drug",
        "designation",
        "treatment",
        "myasthenia",
        "gravis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}